A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India인도의 코비드 전용 병원(DCH)에서 COVID-19 질병 관리를 위한 보조 요법으로서 Ayurcov(AyurCoro3)의 역할을 연구하기 위한 무작위, 통제, 맹검, 병렬 그룹 임상 시험Randomized Controlled Trial Published on 2022-08-012022-09-11 Journal: Complementary therapies in medicine [Category] SARS, 임상, 치료제, [키워드] adjuvant adverse events alternative medicine alum Antiviral Ayurcov Ayurveda blinded CAM carried Chain Reaction clinical trial complementary Complementary and alternative medicine. control group Controlled trial COVID-19 COVID-19 disease COVID-19 infections Ct values Curcuma Day diagnosed discharge disease dose evaluate Formulation functional Functional status higher risk India ingredient Limited management Mild mild to moderate Mild-to-moderate milk moderate outcome parallel group Patient polymerase chain polymerase chain reaction proportion Randomized real time receiving recruited reduction in regimen resolution of symptom reverse transcriptase Reverse transcriptase polymerase chain reaction Rock Candy rRT-PCR severe COVID-19 disease Severe COVID-19 Infection severe symptoms severity significantly significantly lower significantly more Sita Standard of care Symptom symptom resolution therapeutic effect therapeutic options therapy for COVID-19 transcriptase Treatment Urine [DOI] 10.1016/j.ctim.2022.102824 PMC 바로가기 [Article Type] Randomized Controlled Trial
Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron VariantArticle Published on 2022-08-012022-11-15 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] agammaglobulinemia antibody appear collected Concentration COVID-19 Donor Immunity Immunoglobulin immunoglobulin replacement therapy in vitro individual infections Karolinska University Hospital Limited neutralize neutralizing capacity observation omicron original virus strain pandemic Passive passive immunity Patient plasma plasma concentration Prevent Primary Immunodeficiency product Protective reflect remained Sample SARS-CoV-2 SARS-CoV-2 antibody symptomatic the SARS-CoV-2 therapy unit variant were assessed X-linked agammaglobulinemia X-linked agammaglobulinemia. XLA [DOI] 10.1007/s10875-022-01283-9 PMC 바로가기
Acute pulmonary emboli following rebound phenomenon after Nirmatrelvir/Ritonavir treatment for COVID-19Case report Published on 2022-08-012022-10-05 Journal: The American journal of emergency medicine [Category] SARS, 치료법, [키워드] clinician Complication COVID-19 symptom COVID-19: Pulmonary embolism evaluate Evidence highlight hypoxic increasingly Intervention Limited male Mild omicron Patient Paxlovid Paxlovid rebound Pulmonary emboli reported SARS-CoV-2 Symptom Symptoms Treatment treatment for COVID-19 Venous Thromboembolism [DOI] 10.1016/j.ajem.2022.08.012 [Article Type] Case report
Clinical update on COVID-19 for the emergency clinician: Airway and resuscitationReview article Published on 2022-08-012022-10-05 Journal: The American journal of emergency medicine [Category] 임상, [키워드] airway management approach ARDS ARDS patient blocking agent clinical clinically clinician Clinicians Coronavirus-2019 COVID-19 disease dose ECMO extracorporeal membrane oxygenation HFNC IMPROVE indicated Inhaled initial initiated intravenous fluids intubation intubation rate Limited management nasal nippv Non-invasive objective Oxygenation pandemic Patient patient population patients patients with COVID-19 physician Plateau pressure positive pressure ventilation predicted progressed prone provide recruitment SARS-CoV-2 Septic shock severe acute respiratory syndrome coronavirus 2 shown steroid Strategy Support Vasopressor Volume with COVID-19 [DOI] 10.1016/j.ajem.2022.05.011 [Article Type] Review article
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trialArticle Published on 2022-08-012022-10-06 Journal: Lancet Reg Health Southeast Asia [Category] 진단, [키워드] 1:1 95% CI accelerate accelerated age Anti-viral treatment assessment baseline clearance clinical trial Comorbidities comparable Concentration COVID-19 COVID-19 illness defined demonstrated double-blind Endpoint evaluated funding greater greater transmissibility high risk individuals infected with SARS-CoV-2 Laboratory Limited median Mild multicentre mutate nasal Nasal spray nasal swab nitric oxide nostril parallel group Patient pharmaceutical Placebo placebo-controlled polymerase chain primary analysis population progression proportion provided Randomized randomized trial receiving reduce reverse transcription RT-PCR SARS-CoV-2 SARS-CoV-2 RNA secondary Seven study medication symptomatic the placebo group therapy Treatment treatment difference vaccination Viral load virus virus clearance virus RNA [DOI] 10.1016/j.lansea.2022.100036 PMC 바로가기 [Article Type] Article
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age5~11세 어린이의 오미크론에 대한 BNT162b2 백신 효과Article Published on 2022-07-212022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age BNT162b2 BNT162b2 vaccine calculated Care children Cohort Control controls coronavirus coronavirus disease Coronavirus disease 2019 cumulative cumulative incidence dominant variant dose Effectiveness eligible European event Evidence first dose Health Health care incidence Infection Kaplan-Meier estimator Limited Messenger RNA moderate of BNT162b2 omicron Omicron variant outcome provided risk risk difference risk ratio RNA vaccine SARS-CoV-2 SARS-COV-2 infection second dose severe acute respiratory syndrome Coronavirus study group study groups study period subgroups symptomatic COVID-19 the study group the vaccine union Vaccine vaccine doses Year [DOI] 10.1056/NEJMoa2205011 PMC 바로가기 [Article Type] Article
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times불법 물질 사용 및 미국의 Covid-19 Pandemic : 전례없는시기에 연구 증거의 범위 검토 및 특성화Review Published on 2022-07-212022-08-31 Journal: International Journal of Environmental Research an [Category] MERS, 치료제, [키워드] access to treatment article carried change changes in characterization conducted COVID-19 COVID-19 pandemic database determinant effective response Evidence fentanyl harm reduction Health heroin illicit drugs Improved Increases increases in Intervention Limited majority medical record medical records medical service outcome overdose Prevent public health Quantitative Quantitative data reduction reductions reductions in review risk routine monitoring scoping review selected significantly substance Substance use supported the United State threshold time Treatment United States worsening [DOI] 10.3390/ijerph19148883 PMC 바로가기 [Article Type] Review
Vaccination Is Associated With Shorter Time to Target Cycle Threshold Value in Patients With SARS-CoV-2 Omicron Variant백신 접종은 SARS-CoV-2 오미크론 변이가 있는 환자에서 목표 주기 역치 값까지 더 짧은 시간과 관련이 있습니다.Article Published on 2022-07-062022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Alter BBIBP-CorV booster vaccination Characteristics China Chinese CoronaVac coronavirus Course cycle cycle threshold Cycle threshold value disease course had no heterogeneous homologous inactivated Inactivated Vaccines infected with SARS-CoV-2 Infection Isolation life Limited male Mild symptom mild symptoms no difference omicron Omicron variant Patient patients patients with SARS-CoV-2 response retrospective cohort SARS-CoV-2 Science severe acute respiratory syndrome Coronavirus Shanghai Sinopharm Sinovac subject target the disease the mean time vaccination Vaccines value variant [DOI] 10.3389/fcimb.2022.943407 PMC 바로가기 [Article Type] Article
Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvementCOVID-19의 심장-폐 상호작용: 우심실 침범 모니터링을 위한 병상 심장 초음파의 예후 영향 및 유용성Review Published on 2022-07-012022-09-11 Journal: Heart failure reviews [Category] COVID19(2023년), SARS, 치료기술, [키워드] addition adverse effect Afterload appear avoidance circulation Clinical deterioration contribute COVID-19 Critically ill critically ill patients dysfunction echocardiography extracorporeal membrane oxygenation facilitate heart heart failure Heart–lung interaction hemodynamic instability high mortality high risk hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient hospitalized patients Hypoxemia IMPROVE increase in Interaction involved limit Limited management mechanical ventilation medication optimization outcome pathophysiologic Patient patient survival patients with COVID-19 pressure overload prognostic progression pulmonary pulmonary circulation pulmonary vascular resistance Pulmonary vessel thrombosis reducing Respiratory failure right heart failure right ventricle RV dysfunction SARS-COV-2 infection severe COVID-19 small vessel the SARS-CoV-2 thrombosis thrombotic thrombotic microangiopathy tissue damage transthoracic echocardiography Treatment TTE Vascular Vascular resistance ventricular vessel widespread [DOI] 10.1007/s10741-021-10108-7 PMC 바로가기 [Article Type] Review
Impact of COVID-19 on substance use disorder treatment services in Kenya: Qualitative findings from healthcare providersResearch article Published on 2022-07-012022-10-05 Journal: The International Journal on Drug Policy [Category] COVID19(2023년), SARS, 진단, 치료법, [키워드] access age average Care change conducted COVID-19 COVID-19 mitigation COVID-19 pandemic COVID-19 testing described disorder drug females group discussion healthcare Healthcare provider Impact impacted increased risk Injection drug use interview Kenya Limited LMIC male medication overcome participant patients People who inject drugs Personal protective equipment Policy Qualitative reduction resource Result SARS-CoV-2 Social distancing measure Substance use Substance use disorder services thematic analysis transcribed Treatment understanding were used [DOI] 10.1016/j.drugpo.2022.103710 [Article Type] Research article